BTAI BioXcel Therapeutics Inc.

11.39
+0.3  (+3%)
Previous Close 11.09
Open 11.1
Price To Book 7.12
Market Cap 179,139,687
Shares 15,731,395
Volume 5,879
Short Ratio
Av. Daily Volume 27,054

NewsSee all news

  1. BioXcel Therapeutics Announces BXCL501 Program Initiative for Prevention and Treatment of Acute Agitation using Wearable Digital Devices

    Neuropsychiatric patients are vulnerable to multiple agitation episodes; Alzheimer's dementia patients specifically require integrated patient management solutions Expands market potential of BXCL501, if approved,

  2. BioXcel Therapeutics Receives FDA Orphan Drug Designation for BXCL701 for the Treatment of Acute Myeloid Leukemia (AML)

    Expansion of clinical development for BXCL701 program planned in hematological malignancies, beyond solid tumors (Pancreatic and tNEPC) Confirmation and further extension of key findings in Nature Medicine Publication

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial to be initiated 4Q 2019 with data due 1H 2020.
BXCL501
Schizophrenia - Agitation
Phase 1/2 initial data due 2H 2019.
BXCL701 and Keytruda
Neuroendocrine Prostate Cancer (tNEPC)
Phase 1/2 initial data due 1H 2020.
BXCL701
Pancreatic cancer
Phase 1b trial to be initiated 4Q 2019.
BXCL501
Alzheimer’s disease/dementia

Latest News

  1. BioXcel Therapeutics Announces BXCL501 Program Initiative for Prevention and Treatment of Acute Agitation using Wearable Digital Devices

    Neuropsychiatric patients are vulnerable to multiple agitation episodes; Alzheimer's dementia patients specifically require integrated patient management solutions Expands market potential of BXCL501, if approved,

  2. BioXcel Therapeutics Receives FDA Orphan Drug Designation for BXCL701 for the Treatment of Acute Myeloid Leukemia (AML)

    Expansion of clinical development for BXCL701 program planned in hematological malignancies, beyond solid tumors (Pancreatic and tNEPC) Confirmation and further extension of key findings in Nature Medicine Publication